Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Current Status of SARS-CoV-2 Vaccine Development

In this presentation, Professor Sharon Lewin discusses the rapid development of SARS-CoV-2 vaccines and the emerging safety and immunogenicity data from clinical trials investigating several vaccine candidates.
Sharon R. Lewin, AO, FRACP, FAHMS
Released: July 31, 2020

Information on this Educational Activity

Faculty

Sharon R. Lewin, AO, FRACP, FAHMS

Director, The Peter Doherty Institute for Infection and Immunity
Professor of Infectious Diseases
Faculty Medicine Dentistry and Health Sciences
University of Melbourne and Royal Melbourne Hospital
Consultant Infectious Diseases Physician
Department of Infectious Diseases
Royal Melbourne Hospital and Alfred Hospital
Melbourne, Australia

Sharon Lewin, AO, FRACP, PhD, FAAHMS, has disclosed that she has received consulting fees from AbbVie, Gilead Sciences, and ViiV Healthcare; funds for research support from Leidos; and other financial or material support from Gilead Sciences, Merck, and ViiV Healthcare.

Program Medium

This program has been made available online.

Related Content

Watch this presentation by Professor David Heymann discussing the concept of herd immunity and considerations for estimating the herd immunity threshold for SARS-CoV-2

David Heymann, BA, MD, DTM&H Released: September 18, 2020

Download free slides reviewing the latest updates on COVID-19 epidemiology and emerging data on diagnosis, symptoms, management, and treatment

Adaora A. Adimora, MD, MPH Sharon R. Lewin, AO, FRACP, FAHMS Jens D. Lundgren, MD, DMSc Vikramjit Mukherjee, MD Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: September 14, 2020

Presentation by Professor Jens D. Lundgren discussing the current evidence and recommendations regarding the use of convalescent plasma to treat COVID-19 from CCO

Jens D. Lundgren, MD, DMSc Released: September 11, 2020

Watch this concise presentation by Professor Sharon Lewin on durability of antibody and T cell responses to SARS-CoV-2 and the current understanding of reinfection

Sharon R. Lewin, AO, FRACP, FAHMS Released: September 4, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?